Here are four payer-related headlines in the last two weeks for ASCs to know. 1. Medical practices and hospitals saw claims denials increase and prior authorization denials decrease in 2024, according ...

CMS to audit Medicare Advantage plans back to 2018, as part of the Trump administration's efforts at 'crushing fraud, waste and abuse' of healthcare programs UnitedHealth Group Inc. investors had ...

Bucks County, Pa. has initiated legal proceedings against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated effort to inflate ...

Donald Trump's recent executive orders slashing drug prices and demanding transparency in pharmacy benefit manager fees are ...

In a lawsuit announced last week, Bucks County officials accuse pharmacy benefit managers (PBMs) CVS Caremark, Express ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.

The popularity of GLP-1 drugs has insurance companies scrambling to satisfy consumer access while reining in exorbitant costs ...

Illinois officials indicated that the settlement is about a larger issue than just a contract dispute with one PBM.

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Conflicts of interest in the health benefits space are both widespread and increasingly complex, meaning more fuel for more litigation.